BACTEC radiometric susceptibility assay
Mycobacterium tuberculosis H 37 Rv (ATCC 27294) BACTEC 460TB system is a comparatively rapid, radiometric, drug susceptibility assay system for slow growing Mycobacterium species. The BACTEC 460TB system uses BACTEC 12B medium (Middlebrook 7H12), which is basically an improved Middlebrook 7H9 base enriched with additional supplements. Mycobacteria utilised a 14 C-labelled substrate (fatty acid e.g. palmitic acid) present in the 12B medium and 14 CO 2 is released as a result of their metabolic activities. The released gas is then aspirated from the growth vial and the 14 CO 2 radioactivity is determined quantitatively in terms of numbers on a scale from 0 to 999. These numbers are designated as Growth Index (GI). The daily increase in the GI is a measure of growth directly proportional to the rate of metabolic activity of a test bacterium in the medium. If an inhibitory agent is introduced into the medium, production of 14 CO 2 will be less (therefore lower GI) when compared to a control having no inhibitory agent. This instrument detects the metabolism of 14 C-labelled substrate rather than visible growth.
Different stock concentrations of the test compounds were prepared in dimethyl sulphoxide and 40 L of these stocks was transferred into BACTEC 12B vials containing 4.0 mL of culture medium.
Briefly, 0.1mL of bacterial suspension from the primary inoculum culture vial (GI 500) was injected into test compound-containing vials using 1.0 mL insulin syringe. 0.1 mL of primary inoculum was added to 9.9 mL BACTEC diluting fluid to obtain 1:100 dilutions. From this, 0.1 mL was injected into two 12B vials for two test compounds containing 4.0 mL medium along with 40 L of DMSO. Vials were incubated at 37 o C, and the GI was recorded every 24 hours in a BACTEC 460TB instrument (Becton Dickinson). Once the GI of the control vial (1:100) reached 30 then the GI values of the test (compound containing) vials were compared with that of control vials based on difference in growth ( GI). The result was interpreted as follows: If the difference (called GI) of the current GI from the previous day GI in the case of drug containing vials is lower than the GI of the 1:100 control vial for the same period then the test compound is termed as active against MTB or otherwise inactive. Two-fold serial dilution technique was used to assess the minimum inhibitory concentration (MIC) of a test compounds. Only broth culture was used as a positive control and media as a negative control. 
